Submit a utility to the registry.

Filter results using search terms, or by selecting one or more valuation, condition, or population.

Viewing 1 - 10 of 44 results
Title   Year(s) of data collection   Valuation Method   Country   Condition  
Selection of autoimmune disease health state utilities (He A, Spelman T et al., J Neurol Neurosurg Psychiatry. 2023. doi:10.1136/jnnp-2022-330169) 2001 - 2020 EQ-5D-3L Sweden Multiple sclerosis
DOI
10.7910/DVN/XTLOGB
Author(s)
Registry, Utilities
Description
Health state utilities for autoimmune disease conditions
Sample Characteristics
690 adults with relapsing multiple sclerosis in a Swedish registry to examine the association between early treatment of multiple sclerosis and patient-reported outcomes
Title
Selection of mental health health state utilities (Stolz M et al., Eur J Health Econ. 2022. doi:10.1007/s10198-022-01543-w)
Year(s) of data collection
2008 - 2013
Valuation Method
EQ-5D-3L, SF-6D
Country
Germany
Condition
Depression
DOI
10.7910/DVN/QNA5ZF
Author(s)
Registry, Utilities
Description
Health state utilities for mental health conditions
Sample Characteristics
566 cardiac patients with depressive symptoms as part of the SPIRRCAD (Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease) trial
Title
Selection of neurological disease health state utilities (Janssen N et al., J Alzheimers Dis. 2022. doi:10.3233/JAD-215304)
Year(s) of data collection
2009 - 2011
Valuation Method
SF-6D
Country
Finland
Condition
Cognitive decline
DOI
10.7910/DVN/VJSSSX
Author(s)
Registry, Utilities
Description
Health state utilities for neurological disease conditions
Sample Characteristics
1120 participants with longitudinal 2-year data from the FINGER study to investigate the association between cognition, health related quality of life, and costs in a population at risk for cognitive decline
Title
Selection of oncology health state utilities (Konara Mudiyanselage SP et al., Breast Cancer. 2023. doi:10.1007/s12282-022-01413-6)
Year(s) of data collection
2010 - 2021
Valuation Method
EQ-5D
Country
Taiwan (Province of China)
Condition
Breast cancer surgery
DOI
10.7910/DVN/L4V2LU
Author(s)
Registry, Utilities
Description
Health state utilities for oncology conditions
Sample Characteristics
A cohort of 741 women who underwent a mastectomy and breast reconstruction
Title
Selection of neurological disease health state utilities (Lacy B et al., Clin Park Relat Disord. 2023. doi:10.1016/j.prdoa.2022.100180)
Year(s) of data collection
2010 - 2011
Valuation Method
EQ-5D
Country
United States of America
Condition
Parkinson's disease
DOI
10.7910/DVN/VJSSSX
Author(s)
Registry, Utilities
Description
Health state utilities for neurological disease conditions
Sample Characteristics
A cross-sectional study of 124 patients with PD at an academic movement clinic
Title
Selection of autoimmune disease health state utilities (Mitsikostas DD et al., Adv Ther. 2023. doi:10.1007/s12325-022-02388-8)
Year(s) of data collection
2012 - 2016
Valuation Method
EQ-5D-3L
Country
Greece
Condition
Multiple sclerosis
DOI
10.7910/DVN/XTLOGB
Author(s)
Registry, Utilities
Description
Health state utilities for autoimmune disease conditions
Sample Characteristics
A prospective observational study of 458 participants under treatment with fingolimod conducted by hospital-based and private practice neurologists
Title
Selection of orthopedic and musculoskeletal health state utilities (Panzram B et al., J Clin Med. 2023. doi:10.3390/jcm12041694)
Year(s) of data collection
2012 - 2016
Valuation Method
EQ-5D-3L
Country
Germany
Condition
Knee replacement
DOI
10.7910/DVN/VR4XYO
Author(s)
Registry, Utilities
Description
Health state utilities for orthopedic and musculoskeletal conditions
Sample Characteristics
201 participants in a retrospective single-center cohort study of patients who underwent cementless OUKR to investigate the clinical and functional results of cementless unicompartmental knee arthroplasty with a minimum follow up of 5 years
Title
Selection of orthopedic and musculoskeletal health state utilities (Li N et al., J Med Econ. 2022. doi:10.1080/13696998.2022.2087409)
Year(s) of data collection
2014 - 2016
Valuation Method
EQ-5D-5L, SF-6D
Country
Netherlands
Condition
Fracture
DOI
10.7910/DVN/VR4XYO
Author(s)
Registry, Utilities
Description
Health state utilities for orthopedic and musculoskeletal conditions
Sample Characteristics
499 participants in a prospective observational study in a Dutch Fracture Liaison Service clinic
Title
Selection of orthopedic and musculoskeletal health state utilities (Zhou AK et al., Eur J Orthop Surg Traumatol. 2023. doi:10.1007/s00590-022-03204-3)
Year(s) of data collection
2014 - 2021
Valuation Method
EQ-5D-5L
Country
United Kingdom of Great Britain and Northern Ireland
Condition
Open talus fractures
DOI
10.7910/DVN/VR4XYO
Author(s)
Registry, Utilities
Description
Health state utilities for orthopedic and musculoskeletal conditions
Sample Characteristics
14 participants from the review of electronic hospital records, cohort
Title
Selection of oncology health state utilities (Yang M et al., Value Health. 2023. doi:10.1016/j.jval.2023.02.00)
Year(s) of data collection
2016 - 2021
Valuation Method
EQ-5D-5L
Country
Austria, Belgium, China, France, Germany, Israel, Italy, Japan, Korea (Republic of), Netherlands, Poland, Spain, Switzerland, Taiwan (Province of China), United States of America
Condition
Lung cancer
DOI
10.7910/DVN/L4V2LU
Author(s)
Registry, Utilities
Description
Health state utilities for oncology conditions
Sample Characteristics
273 patients with non-small cell lung cancer harboring MET exon 14 skipping treated with tepotinib